We have shown that COL11A1 enhances Src/Akt/NFκB activation in human ovarian cancer cell lines, leading to upregulation of inhibitor of apoptosis protein (IAP) expression (BIRC2, BIRC3, XIAP) [63]. Here, COL11A1 is linked to ovarian cancer.